Current role
Drug Discovery
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Drug Discovery
The proxy statement of Biocryst Pharmaceuticals Inc reports total compensation of $1,639,444 for Drug Discovery in fiscal 2017, including a base salary of $382,480.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Biocryst Pharmaceuticals Inc (BCRX)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Biocryst Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Charles Gayer CEO, Board Member
- Charlie Gayer CEO, Board Member
- Vincent J. Milano Chairman, Board Member
- Babar Ghias CFO, Chief Accounting Officer
- Jon P. Stonehouse CFO, Chief Accounting Officer, Board Member
- Thomas R. Staab II CFO
- A. Machelle Sanders Board Member
- Alan G. Levin Board Member
- Amy E. McKee Board Member
- Amy E. McKee, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2017 | Biocryst Pharmaceuticals Inc (BCRX) | — | $382,480 | $1,639,444 |
Recent activity
No call appearances or filed executive changes recorded yet.